Covid-19 and the risk to the supply and quality of drugs

Our news

Covid-19 and the risk to the supply and quality of drugs

As COVID-19 research continues, it is critical that any approved drugs are safe and can be accessed by everybody throughout the world. 55 members of the campaign Medicines We Can Trust,from 20 countries,including David Richmond and Kim Doyle, CEO and Director of the Programmes and Partnerships of the Brazzaville Foundation, co-signed the article "COVID-19 and risks to the supply and quality of tests, drugs, and vaccines" published yesterday in The Lancet.
Access the article via the link : https://bit.ly/3aZ9Awi